Latest debt-to-equity ratio
Sonoma Pharmaceuticals Debt-to-equity ratio
Direct answer
Sonoma Pharmaceuticals's debt-to-equity ratio is 11.21%.
The verified market snapshot reports 11.21%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free Sonoma Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 11.21%
Explore related company data
View Sonoma Pharmaceuticals's market capitalizationView Sonoma Pharmaceuticals's price-to-book ratioView Sonoma Pharmaceuticals's return on equityView Sonoma Pharmaceuticals's dividend yieldView Sonoma Pharmaceuticals's 52-week price rangeView Sonoma Pharmaceuticals's revenue growthView Sonoma Pharmaceuticals's profit marginView all Sonoma Pharmaceuticals key metricsReturn to Sonoma Pharmaceuticals profile